Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J M Groen

Showing results (91-100 of 274) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|September 19, 2017
Dabrafenib plus trametinib in patients with previously untreated BRAF<sup>V600E</sup>-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trialDavid Planchard, Egbert F Smit, Harry J M Groen, et al.
European Journal of Clinical Pharmacology|March 10, 2010
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismJan Gerard Maring, Floris M Wachters, Monique Slijfer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2011
Modest improvements of survival for patients with small cell lung cancer aged 45 to 59 years only, diagnosed in the Netherlands, 1989 to 2008Maryska L G Janssen-Heijnen, Henrike E Karim-Kos, Miep A van der Drift, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2016
A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine TumorsJules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Cancers|October 21, 2020
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison StudyPierre-Jean Lamy, Paul van der Leest, Nicolas Lozano, et al.
Chest|June 23, 2012
Lung function decline in male heavy smokers relates to baseline airflow obstruction severityFirdaus A A Mohamed Hoesein, Pieter Zanen, H Marike Boezen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2025
Cost-effectiveness and budget impact of lung cancer screening in time of immunotherapyDanrong Zhong, Grigory Sidorenkov, Keris Poelhekken, et al.
Journal of Thoracic Disease|August 23, 2021
A contrast-enhanced-CT-based classification tree model for classifying malignancy of solid lung tumors in a Chinese clinical populationXiaonan Cui, Marjolein A Heuvelmans, Grigory Sidorenkov, et al.
BMC Genomics|August 19, 2007
Microarray amplification bias: loss of 30% differentially expressed genes due to long probe - poly(A)-tail distancesMirjam C Boelens, Gerard J te Meerman, Johan H Gibcus, et al.
European Radiology|June 9, 2022
Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3)Xiaofei Yang, Monique D Dorrius, Wenzhen Jiang, et al.
Pageof 28

Showing results (91-100 of 274) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|September 19, 2017
Dabrafenib plus trametinib in patients with previously untreated BRAF<sup>V600E</sup>-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trialDavid Planchard, Egbert F Smit, Harry J M Groen, et al.
European Journal of Clinical Pharmacology|March 10, 2010
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismJan Gerard Maring, Floris M Wachters, Monique Slijfer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2011
Modest improvements of survival for patients with small cell lung cancer aged 45 to 59 years only, diagnosed in the Netherlands, 1989 to 2008Maryska L G Janssen-Heijnen, Henrike E Karim-Kos, Miep A van der Drift, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2016
A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine TumorsJules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Cancers|October 21, 2020
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison StudyPierre-Jean Lamy, Paul van der Leest, Nicolas Lozano, et al.
Chest|June 23, 2012
Lung function decline in male heavy smokers relates to baseline airflow obstruction severityFirdaus A A Mohamed Hoesein, Pieter Zanen, H Marike Boezen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2025
Cost-effectiveness and budget impact of lung cancer screening in time of immunotherapyDanrong Zhong, Grigory Sidorenkov, Keris Poelhekken, et al.
Journal of Thoracic Disease|August 23, 2021
A contrast-enhanced-CT-based classification tree model for classifying malignancy of solid lung tumors in a Chinese clinical populationXiaonan Cui, Marjolein A Heuvelmans, Grigory Sidorenkov, et al.
BMC Genomics|August 19, 2007
Microarray amplification bias: loss of 30% differentially expressed genes due to long probe - poly(A)-tail distancesMirjam C Boelens, Gerard J te Meerman, Johan H Gibcus, et al.
European Radiology|June 9, 2022
Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3)Xiaofei Yang, Monique D Dorrius, Wenzhen Jiang, et al.
Pageof 28